Skip Navigation

Fake malaria drugs not as common as previously reported

Researchers welcome reassuring findings but note poor quality drugs are still a problem. Read the latest research from Cambodia & Tanzania in the American Journal of Tropical Medicine and Hygiene.

Videos and more

Visit our multimedia section to watch videos and animations, browse a prezi and listen to podcasts with ACT Consortium investigators talking about their studies on the access, targeting, quality and safety of ACT drugs.

Malaria research publications

Browse through more than 80 journal articles published by ACT Consortium investigators on the access, targeting, safety and quality of antimalarials.

News from our Partners

Three projects funded by the Malaria Eradication Scientific Alliance (MESA) in Cambodia, Kenya and Tanzania looked at ways to reduce efficacy decay of malaria interventions in different settings, and the feasibility of clearing parasites from asymptomatic people.

View all ACT Consortium news

The ACT Consortium is an international research collaboration formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.  

Our goal is to develop and evaluate delivery mechanisms to improve ACT access, targeting, safety and quality. 

The ACT Consortium is funded by the Bill & Melinda Gates Foundation and has partners throughout Africa, Asia, Europe and the United States.  It is coordinated through the London School of Hygiene & Tropical Medicine.